RBM47 and breast cancer: These correlative analyses of multiple different breast cancer data sets, both experimental systems and large clinical patient cohorts, suggested that reduced expression or function of RBM47 is associated with breast cancer progression already within primary tumors, and that clones with reduced RBM47 function may display enhanced lung and brain metastatic fitness.